Olon Ricerca bioscience
Change/Challenge and innovate the way to deliver science to improve health of all human beings
Being part of the Olon CDMO Division, Olon Ricerca Bioscience is following the Five Strong Pillars concept, to ensure that the company consistently meet or exceed customers’ expectations.
Excellent customer service requires an in-depth understanding of the customer’s needs. Across the Olon Group, flexibility is also essential because projects may be initiated at any of our sites but require support from different or multiple locations.
Cooperation is therefore also fundamental to achieving QOTIF. Having the same quality system across the entire group provides assurance to our customers that their products will be produced to the same exacting standards throughout the lifetime of each project.
Olon Group, as a whole, has the ability to support customers from early-phase development to commercial production and to produce milligrams to tons of material. These capabilities are backed by the strong financial stability of the company. We are also interested in being strategic partners with our customers and are committed to forming long-term, risk-sharing, win-win relationships.
Our management approach involves the use of dedicated project teams that support each project from start to finish. This approach allows for excellent communication and the building of strong relationships between Olon Ricerca Bioscience scientists and our clients. We have, in fact, had many customers that bring us repeat business, where clients specifically request the same project teams.
The security of customer information is absolutely essential.
At Olon, we take this issue seriously and have procedures in place to ensure that security is maintained at all times. In addition, we cooperate with our customers to ensure that appropriate measures are implemented to protect their information.
Cost management is always an issue for any business and it is of particular concern today for the pharmaceutical industry. Because Olon is involved in the generics market, where competition is largely based on pricing, we have gained experience in achieving cost-effective production methods. This experience is then applied to projects implemented by our CRO/CDMO businesses to the benefit of our customers.
Olon Ricerca Bioscience takes great pride in giving back. We have a strong commitment to improve the quality of life in our community. Being good neighbors is more than just an idea; it is the driving force in how we do business.
Olon Ricerca Bioscience employees seek out local groups and events with which to share its donations of food, time and money.
By enlisting the volunteer spirit of our dedicated employees, we create awareness and support of local groups and help build our communities from within.
The Five Strong Pillars include:
Chief Executive Officer
Luigi Trussardo is the CEO of Olon Ricerca Bioscience, a US-based CRO supporting the development and manufacture of APIs and performance materials in support clinical supply, market development and commercial distribution.
He has more than 30 years experience in the pharmaceutical industry and healthcare business, working for multinational companies in the field of clinical diagnostic, medical devices and fine chemical business.
Luigi received a BS in biology from Milan University.
Dorothie L. Okleson
Chief Financial Officer
Dorothie Okleson is responsible for Finance, IT, HR and Supply Chain functions. In this role, she is responsible for all accounting and financial reporting requirements, cash management activities, and managing all other support functions on behalf of the company.
She supports all business operations within the company, controlling budgets and cash flow, and manages all capital investments. Dorothie has served many finance roles in her 39 years of service with the company.
She received her BS in Accountancy from Lake Erie College in Painesville, Ohio. She is also a Certified Public Accountant.
Michael D. Contenza
Michael is currently the General Manager of Olon Ricerca Bioscience located in Concord, Ohio where he is responsible for business and operational activities. In his current role Michael has direct responsibility for the operating units, quality assurance, environmental health and safety, and facilities management. Michael’s 40 years in the pharmaceutical and chemical industries has consisted of a broad range of operational and technical responsibilities including operational and business management; technology assessment, development and transfer; project engineering; business and strategic relationship development; capital planning and implementation; quality/cGMP system development and compliance; and environmental, health and safety management.
Michael earned his B.S in Chemical Engineering from Case Western Reserve University and his M.S from Cleveland State University. Michael is a registered and licensed professional engineer in the State of Ohio.